Andreas Lindauer
Impact in
- Oncology top 5%
- Metal complexes synthesis and properties
- Cancer Immunotherapy and Biomarkers
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Pharmaceutical studies and practices 6
- Oncology 6
- Cancer Immunotherapy and Biomarkers 3
- Metal complexes synthesis and properties 2
- Co-authors
- Ulrich Jaehde (8 shared papers)Rik de Greef (3 shared papers)Jeroen Elassaiss‐Schaap (3 shared papers)Friederike Kanefendt (3 shared papers)Uwe Fuhr (3 shared papers)Oxana Doroshyenko (1 shared paper)Bernhard K. Keppler (2 shared papers)Juergen Wolf (1 shared paper)
- Journals
- CPT Pharmacometrics & Systems Pharmacology (6 papers)Clinical Pharmacokinetics (3 papers)Therapeutic Drug Monitoring (2 papers)Clinical Pharmacology & Therapeutics (1 paper)Pharmaceutics (1 paper)
- Partner nations
- GermanyUnited StatesBelgium
In The Last Decade
Andreas Lindauer
19 papers receiving 824 citations
Peers
Comparison fields: 5 of 76
- Oncology 442
- Pharmacology 97
- Modeling and Simulation 39
- Statistics and Probability 56
- Pediatrics, Perinatology and Child Health 57
Countries citing papers authored by Andreas Lindauer
This map shows the geographic impact of Andreas Lindauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Lindauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Lindauer more than expected).
Fields of papers citing papers by Andreas Lindauer
This network shows the impact of papers produced by Andreas Lindauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Lindauer. The network helps show where Andreas Lindauer may publish in the future.
Co-authors
The 25 scholars most cited alongside Andreas Lindauer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 220 | |
| 2 | 2011 | 195 | |
| 3 | 2016 | 102 | |
| 4 | 2016 | 100 | |
| 5 | 2016 | 72 | |
| 6 | 2010 | 48 | |
| 7 | 2020 | 25 | |
| 8 | 2015 | 21 | |
| 9 | 2012 | 16 | |
| 10 | 2008 | 15 | |
| 11 | 2012 | 9 | |
| 12 | 2010 | 7 | |
| 13 | 2019 | 6 | |
| 14 | 2017 | 5 | |
| 15 | 2024 | 3 | |
| 16 | 2024 | 2 | |
| 17 | 2004 | 1 | |
| 18 | 2025 | 1 | |
| 19 | 2025 | 1 |
About Andreas Lindauer
Andreas Lindauer is a scholar working on Pediatrics, Perinatology and Child Health, Oncology, Pharmacology, Statistics and Probability and Psychiatry and Mental health, having authored 19 papers that have together received 849 indexed citations. Recurring topics across this work include Pharmaceutical studies and practices (6 papers), Cancer Immunotherapy and Biomarkers (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Statistical Methods in Clinical Trials (3 papers), Schizophrenia research and treatment (2 papers), Metal complexes synthesis and properties (2 papers), Angiogenesis and VEGF in Cancer (2 papers) and Epilepsy research and treatment (1 paper). The work is most often cited by research in Oncology (442 citations), Pharmacology (97 citations), Modeling and Simulation (39 citations), Statistics and Probability (56 citations) and Pediatrics, Perinatology and Child Health (57 citations). Andreas Lindauer has collaborated with scholars based in Germany, United States and Belgium. Frequent co-authors include Ulrich Jaehde, Rik de Greef, Jeroen Elassaiss‐Schaap, Friederike Kanefendt, Uwe Fuhr, Oxana Doroshyenko, Bernhard K. Keppler, Juergen Wolf, Matthias Scheffler and Max Ernst Scheulen. Their work appears in journals such as CPT Pharmacometrics & Systems Pharmacology, Clinical Pharmacokinetics, Therapeutic Drug Monitoring, Clinical Pharmacology & Therapeutics and Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.